While the exact mechanisms aren't fully understood, both clinical trial data and post-marketing experience suggest that fatigue can occur with semaglutide treatment through multiple pathways
The key difference is customization: your clinician can adjust strength and dosing frequency based on genetic testing and clinical response, improving both efficacy and safety
: 400
Lotte: That's the next level of the conversation that could be really interesting because actually for us, the target market was also obesity from the beginning
One of the most common factors leading to COPD is a history of smoking, although other particulate matter exposures, chemical exposures, respiratory infections, chronic bronchitis, asthma, and genetic susceptibility can also affect incidence (Yoshida and Tuder, 2007
USA 104 , 28312836 (2007)